Atara, Already Slapped With CRL, Gets A Clinical Hold As Well
The FDA placed a clinical hold on the cell therapy firm’s active INDs that affects Ebvallo and ATA3219 and is connected to the recent complete response letter for Ebvallo.
The FDA placed a clinical hold on the cell therapy firm’s active INDs that affects Ebvallo and ATA3219 and is connected to the recent complete response letter for Ebvallo.